Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfeb15feb6494dd2bbaf738f4c72e216 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-0038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-479 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-4133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-64 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-44721 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-447 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-53 |
filingDate |
2017-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c1d99eeac262a2a0adc298a1663d1e |
publicationDate |
2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10330638-B2 |
titleOfInvention |
Method and apparatus to characterize pressurized liquid sample |
abstract |
A method for measuring the physical properties of a drug formulation suspended in a pressurized liquid propellant and a system to enable such measurements is disclosed. Drug formulations suspended in pressurized liquid propellant used in Pressurized Metered Dose Inhalers (pMDIs) are propelled in their native liquid state into an analytical instrument with a measurement cell capable of withstanding the pressure required to retain the sample in liquid form by employing a device to rapidly release the contents of the pMDI canister into the measurement instrument wherein the sample's electrophoretic mobility and size may be determined by MP-PALS or other techniques. A series of valves permits the maintenance of the high pressure in the system. Once the measurements are made, the pressurized liquid is allowed to pass to waste or another analytical instrument by opening an exit valve. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10837942-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019317045-A1 |
priorityDate |
2017-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |